Interpreting Key Trials

African Americans with hypertensive kidney disease benefit from an ACE inhibitor

Initial findings of the AASK

Author and Disclosure Information

ABSTRACTExperts have long thought that African Americans were less responsive to ACE inhibitors than other racial or ethnic groups. The African American Study of Kidney Disease and Hypertension (AASK) provides the first evidence of a beneficial effect of ACE inhibition on renal function in African American patients, in addition to excellent blood pressure control.


 

Next Article: